Pharmacyclics
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Pharmacyclics sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
Pharmacyclics: 54 sponsored US clinical trials, none currently recruiting.
Pharmacyclics sponsors 54 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 46 completed. 11 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Myeloma, with 3 trials.
Top-decile sponsor footprint
Pharmacyclics ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
46 of 54 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
54 total, page 2 of 2
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
NCT00086034
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
NCT00080028
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
NCT00076401
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
NCT00121420
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 19 |
| Phase 3 | 11 |
How the Pharmacyclics early-phase archive is shaped
54 indexed studies, none listed as recruiting (0% open); 46 completed (85%).
Phase mix: 11 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Multiple Myeloma (3 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Pharmacyclics: archived-pipeline peers nationwide
Peers matched on 54 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Pharmacyclics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 archived trials
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Pharmacyclics page
54 registered trials is a research-attention snapshot, not an endorsement of Pharmacyclics or any single study.
- None of Pharmacyclics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Multiple Myeloma is the condition Pharmacyclics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Myeloma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pharmacyclics pipeline card: 54 registered trials from official public datasets.Report a data error.